192 related articles for article (PubMed ID: 25326807)
1. Cripto-1 expression and its prognostic value in human bladder cancer patients.
Wei B; Jin W; Ruan J; Xu Z; Zhou Y; Liang J; Cheng H; Jin K; Huang X; Lu P; Hu Q
Tumour Biol; 2015 Feb; 36(2):1105-13. PubMed ID: 25326807
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma.
Wang JH; Wei W; Xu J; Guo ZX; Xiao CZ; Zhang YF; Jian PE; Wu XL; Shi M; Guo RP
Oncotarget; 2015 Oct; 6(33):35116-28. PubMed ID: 26375669
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer.
Ruan J; Wei B; Xu Z; Yang S; Zhou Y; Yu M; Liang J; Jin K; Huang X; Lu P; Cheng H
Med Oncol; 2013 Mar; 30(1):445. PubMed ID: 23307254
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer.
Xu CH; Sheng ZH; Hu HD; Hao KK; Wang QB; Yu LK
Tumour Biol; 2014 Sep; 35(9):8673-8. PubMed ID: 24870591
[TBL] [Abstract][Full Text] [Related]
5. The Function and Prognostic Significance of Cripto-1 in Colorectal Cancer.
Sato J; Karasawa H; Suzuki T; Nakayama S; Katagiri M; Maeda S; Ohnuma S; Motoi F; Naitoh T; Unno M
Cancer Invest; 2020 Apr; 38(4):214-227. PubMed ID: 32157913
[TBL] [Abstract][Full Text] [Related]
6. High cripto-1 and low miR-205 expression levels as prognostic markers in early stage non-small cell lung cancer.
Park KS; Moon YW; Raffeld M; Lee DH; Wang Y; Giaccone G
Lung Cancer; 2018 Feb; 116():38-45. PubMed ID: 29413049
[TBL] [Abstract][Full Text] [Related]
7. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
8. High expression of constitutive photomorphogenic 1 (COP1) is associated with poor prognosis in bladder cancer.
Li J; Wang L; Xiao R; Pan Q; Huang H; Kuang R
Tumour Biol; 2016 Jul; 37(7):8917-22. PubMed ID: 26753957
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of cripto-1 expression in non-small-cell lung cancer patients: a systematic review and meta-analysis.
Wei Y; Jiang J; Wang C; Zou H; Shen X; Jia W; Jin S; Zhang L; Hu J; Yang L; Pang L
Biomark Med; 2020 Mar; 14(4):317-329. PubMed ID: 32134335
[No Abstract] [Full Text] [Related]
10. [Expression and Prognostic Value of Cripto-1 in Pancreatic Cancer].
Gao X; Xu Q; Zhang RH; Lu T; Pan BJ; Liao Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Apr; 43(2):173-179. PubMed ID: 33966694
[TBL] [Abstract][Full Text] [Related]
11. Cripto-1 expression in patients with clear cell renal cell carcinoma is associated with poor disease outcome.
Xue YJ; Chen SN; Chen WG; Wu GQ; Liao YF; Xu JB; Tang H; Yang SH; He SY; Luo YF; Wu ZH; Huang HW
J Exp Clin Cancer Res; 2019 Aug; 38(1):378. PubMed ID: 31455359
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer.
Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y
Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of KAI1 metastasis suppressor gene is a recurrence predictor in primary pTa and pT1 urothelial bladder carcinoma.
Su JS; Arima K; Hasegawa M; Franco OE; Umeda Y; Yanagawa M; Sugimura Y; Kawamura J
Int J Urol; 2004 Feb; 11(2):74-82. PubMed ID: 14706010
[TBL] [Abstract][Full Text] [Related]
14. Cripto: Expression, epigenetic regulation and potential diagnostic use in testicular germ cell tumors.
Spiller CM; Gillis AJ; Burnet G; Stoop H; Koopman P; Bowles J; Looijenga LH
Mol Oncol; 2016 Apr; 10(4):526-37. PubMed ID: 26654129
[TBL] [Abstract][Full Text] [Related]
15. Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma.
Wu Z; Li G; Wu L; Weng D; Li X; Yao K
BMC Cancer; 2009 Sep; 9():315. PubMed ID: 19732464
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-148a represents an independent prognostic marker in bladder cancer.
Ma L; Xu Z; Xu C; Jiang X
Tumour Biol; 2016 Jun; 37(6):7915-20. PubMed ID: 26700670
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of ESCO1 is correlated with poor patient survival and its role in human bladder cancer.
Zhang S; Li J; Zhou G; Mu D; Yan J; Xing J; Yao Z; Sheng H; Li D; Lv C; Sun B; Hong Q; Guo H
Tumour Biol; 2016 Apr; 37(4):5165-70. PubMed ID: 26547586
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and biological significance of cripto overexpression in human colon cancer.
Jiang PC; Zhu L; Fan Y; Zhao HL
World J Gastroenterol; 2013 Dec; 19(46):8630-7. PubMed ID: 24379580
[TBL] [Abstract][Full Text] [Related]
19. DCAMKL1 is associated with the malignant status and poor outcome in bladder cancer.
Zhang S; Zhang G; Guo H
Tumour Biol; 2017 Jun; 39(6):1010428317703822. PubMed ID: 28621231
[TBL] [Abstract][Full Text] [Related]
20. Serum Dickkopf-1 levels as a clinical and prognostic factor in patients with bladder cancer.
Sun DK; Wang L; Wang JM; Zhang P
Genet Mol Res; 2015 Dec; 14(4):18181-7. PubMed ID: 26782465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
